Axsome Therapeutics Inc

29 Oct 2026, 20:02 UTC

Mizuho analyst Graig Suvannavejh lowered Axsome Therapeutics' price target to $284.00 from $316.00 while keeping an Outperform rating.

28 Oct 2026, 20:21 UTC

Axsome Therapeutics, Inc. is trading modestly higher in after-market hours, supported by gains in the Pharmaceuticals sub-sector, shifting from a slight loss since Wednesday's close.

27 Oct 2026, 20:01 UTC

Axsome Therapeutics, Inc. shares fell sharply, retracing from an early high and continuing a decline with five consecutive sessions of losses.

26 Oct 2026, 21:01 UTC

Axsome Therapeutics Inc shares advanced modestly during after-market hours on Monday, marking the highest cumulative return of the session following recent pressure.

23 Oct 2026, 23:06 UTC

Axsome Therapeutics Inc is trading modestly higher in after-market hours, in line with broader market trends despite mixed economic signals and rising oil prices.

22 Oct 2026, 20:13 UTC

Axsome Therapeutics Inc shares are trading modestly lower in after-market hours, continuing a notably weak performance below its 20-day moving average.

21 Oct 2026, 23:11 UTC

Axsome Therapeutics Inc is trading higher in after-market hours, rebounding from a brief dip earlier in the session and reaching its highest point of the day.

20 Oct 2026, 23:51 UTC

Axsome Therapeutics Inc shares advanced sharply in after-market trading, rising from a low shortly after the market closed to a session high.

19 Oct 2026, 23:56 UTC

Axsome Therapeutics Inc shares are trading higher in after-market hours, having pulled back from an initial gain shortly after the market closed.

16 Oct 2026, 20:07 UTC

Axsome Therapeutics Inc shares are declining, consistent with broader market weakness, reaching their lowest point since Thursday's close amid a subdued trading environment.

15 Oct 2026, 20:07 UTC

Axsome Therapeutics Inc shares are declining, following volatility earlier in the session, and remain significantly below their 20-day moving average.

14 Oct 2026, 21:01 UTC

Axsome Therapeutics Inc shares are moving lower in after-market trading amid a broader market decline following increased inflation concerns and potential Fed interest rate hikes.

13 Oct 2026, 20:01 UTC

Axsome Therapeutics Inc shares fell sharply, breaking a recent trend of higher daily closes, contrasting with the upward momentum observed since Monday's close.

12 Oct 2026, 23:41 UTC

Axsome Therapeutics Inc shares advanced in after-market trading, showing gains after an initial dip, despite a broader decline over the past month.

9 Oct 2026, 19:35 UTC

Axsome Therapeutics Inc shares fell sharply during the current market session, reflecting a broader trend of lower daily closes over the past month.

8 Oct 2026, 23:01 UTC

Axsome Therapeutics Inc shares are modestly lower in after-market trading, continuing a downward trend since Thursday's close and remaining below its 20-day moving average.

7 Oct 2026, 20:08 UTC

Axsome Therapeutics Inc shares fell as the company announced its third-quarter financial results will be released on November 2, 2026, before market open.

6 Oct 2026, 22:35 UTC

Axsome Therapeutics Inc's shares are higher in after-market hours, despite a recent decline and nine consecutive sessions finishing lower.

5 Oct 2026, 19:35 UTC

Axsome Therapeutics Inc shares fell, continuing a downward trend with seven consecutive sessions of lower closes since the market opened.

2 Oct 2026, 20:12 UTC

Axsome Therapeutics Inc is trading modestly lower in after-market hours, continuing a trend with six consecutive sessions finishing lower.

1 Oct 2026, 20:07 UTC

Axsome Therapeutics Inc shares fell sharply, closing lower than Wednesday and remaining significantly below the 20-day moving average.

30 Sept 2026, 21:01 UTC

Axsome Therapeutics Inc's shares rose in after-market trading, supported by positive economic indicators, including stronger GDP growth and robust personal spending.

29 Sept 2026, 20:01 UTC

Shares of Axsome Therapeutics fell as Deutsche Bank maintained its Buy rating but lowered the price target to $267 amid reevaluated market conditions.

28 Sept 2026, 20:07 UTC

Axsome Therapeutics Inc shares fell amid a broader market downturn, despite presenting new Alzheimer’s agitation survey data at Psych Congress 2026.

25 Sept 2026, 20:07 UTC

Axsome Therapeutics shares fell after Morgan Stanley cut its price target to $247 from $251, contributing to a decline near the lower end of its one-month range.

24 Sept 2026, 20:07 UTC

Axsome Therapeutics Inc's shares advanced, recovering from four consecutive sessions of losses, though they remain below their 20-day moving average.

23 Sept 2026, 23:35 UTC

Axsome Therapeutics Inc is trading modestly higher in after-market hours following unusual activity, though it remains significantly below its 20-day moving average.

22 Sept 2026, 19:45 UTC

Axsome Therapeutics Inc shares fell sharply, trading below their 20-day moving average, marking three consecutive sessions of declines amid a weaker market trend.

21 Sept 2026, 20:12 UTC

Axsome Therapeutics Inc is trading modestly lower in after-market hours, remaining near the lower end of its one-month trading range and below its 20-day moving average.

18 Sept 2026, 19:46 UTC

Axsome Therapeutics Inc shares fell after reaching an early high, remaining below Thursday's close and stabilizing around the middle of its one-month trading range.